Literature DB >> 14706971

Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis.

Sergio A Jimenez1, Chris T Derk.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14706971

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  96 in total

1.  The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses.

Authors:  Feng Fang; Kohtaro Ooka; Swati Bhattacharyya; Swati Bhattachyya; Jun Wei; Minghua Wu; Pan Du; Simon Lin; Francesco Del Galdo; Carol A Feghali-Bostwick; John Varga
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Pulmonary arterial hypertension associated with systemic sclerosis.

Authors:  Stephen C Mathai; Paul M Hassoun
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

Review 3.  Lung involvement in systemic sclerosis.

Authors:  Paul M Hassoun
Journal:  Presse Med       Date:  2010-12-30       Impact factor: 1.228

4.  Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study.

Authors:  Chris T Derk; Carol M Artlett; Sergio A Jimenez
Journal:  Clin Rheumatol       Date:  2006-01-25       Impact factor: 2.980

Review 5.  [Laboratory diagnostics for systemic sclerosis].

Authors:  R Mierau; A Roers; E Genth
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

6.  Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin.

Authors:  Raffaele De Palma; Francesco Del Galdo; Salvatore Lupoli; Paolo Altucci; Gianfranco Abbate; Gabriele Valentini
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

7.  Acute myocardial infarction in systemic sclerosis patients: a case series.

Authors:  Chris T Derk; Sergio A Jimenez
Journal:  Clin Rheumatol       Date:  2006-03-07       Impact factor: 2.980

8.  Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.

Authors:  Minghua Wu; Denisa S Melichian; Eric Chang; Matthew Warner-Blankenship; Asish K Ghosh; John Varga
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

9.  Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis.

Authors:  Joel Rosenbloom; Sergio A Jiménez
Journal:  Arthritis Rheum       Date:  2008-08

10.  Connective tissue growth factor/CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-beta responsiveness.

Authors:  Yasuji Mori; Monique Hinchcliff; Minghua Wu; Matthew Warner-Blankenship; Karen M Lyons; John Varga
Journal:  Exp Cell Res       Date:  2007-12-23       Impact factor: 3.905
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.